Data & Statistics

Trends, Morbidity, Mortality, and Cost of Hospitalizations Associated with Infectious Disease Sequelae of the Opioid Epidemic Report 

Viral Hepatitis Unit Annual Report

Annual report detailing yearly hepatitis statistics. Within the report is information on hepatitis B and C infection by age, gender and race, the risk behaviors associated with hepatitis B and C infection, and hepatitis coinfection with HIV in Michigan. Also included are maps of the rates of hepatitis B and C by county, local health jurisdiction, and region.
2012 Hepatitis B and C Surveillance Report
2013 Hepatitis B and C Surveillance Report
2014 Hepatitis B and C Surveillance Report
2015 Hepatitis B and C Surveillance Report
2016 Hepatitis B and C Surveillance Report
2017 Hepatitis B and C Surveillance Report
NEW!!! 2018 Hepatitis B and C Surveillance Report

Local Health Department Hepatitis C Virus Surveillance Data Quality Reports

This feedback report is designed to inform local health departments of their Hepatitis C Virus variable completion rates in the MDSS.  This report is not meant to be punitive, but to help LHDs understand where they stand relative to their peers. 

We hope that this tool can be utilized to target data quality improvement.  Where appropriate, disease investigators may be able to use this report to demonstrate programmatic successes or to make a case for additional resources.

Local Health Departments are identified by a code in this report.  Please contact HartA6@michigan.gov or MDHHS-Hepatitis@michigan.gov so that we may provide you with your LHD code.

2017 Q2 HCV Data Quality Report 
2017 Q3 HCV Data Quality Report 
2017 Q4 HCV Data Quality Report 
2018 Q1 HCV Data Quality Report 
2018 Q2 HCV Data Quality Report 
2018 Q3 HCV Data Quality Report 
2018 Q4 HCV Data Quality Report 
2019 Q1 HCV Data Quality Report 

2019 Q2 HCV Data Quality Report
2019 Q3 HCV Data Quality Report

Local Health Department Hepatitis C Virus Surveillance Report

This monthly report is designed to inform local health departments of Hepatitis C Virus (HCV) cases reported to the Michigan Disease Surveillance System (MDSS) that may be related to injection drug use.  These cases include all acute HCV cases and chronic HCV cases among persons aged 18 to 29. Also included are the number of ED visits related to injection drug use that were reported to the Michigan Syndromic Surveillance System (MSSS).  The purpose of the report is to highlight areas where transmission of HCV may be occurring among people who inject drugs.  The goal is that, when warranted, this information will lead to more timely and effective public health intervention.

Please see our separate document on Technical Notes for how these data are obtained and defined and limitations to the data.

2016 Q1 HCV Surveillance Report
2016 Q2 HCV Surveillance Report
2016 Q3 HCV Surveillance Report
2016 Q4 HCV Surveillance Report
2017 Q2 HCV Surveillance Report
2017 Q3 HCV Surveillance Report
2017 Q4 HCV Surveillance Report
2018 Q1 HCV Surveillance Report
2018 Q2 HCV Surveillance Report
2018 Q3 HCV Surveillance Report
2018 Q4 HCV Surveillance Report
2019 Q1 HCV Surveillance Report

2019 Q2 HCV Surveillance Report
2019 Q3 HCV Data Quality Report

For questions, feedback, or additional requests for data please contact us at MDHHS-Hepatitis@michigan.gov